What mainly interests me in the whitelabelling is the pooling of maintenance (less costs and worries) and the future possibility of researching citizen science like we discussed a while ago. The former I think will be the case for all clients, the latter is more specific.
Open Insulin was an attempt on the old platform to do this meta research. It didn’t work out, but we learned and I’m still very interested. If the research thing can better be done later on, that’s okay. Then again, if it is done now, nothing prevents you or others of playing with the data and possibly discovering things that can lead to a next project. From our experience, opening up possibility spaces like that can be very valuable.
Considering your plans of possibly selling this as a product, I invite you to also think what you would like to test out with us as an early client. What do you want to offer for what price? And what is the investment you’ll need to make (as described in more detail by @matthias in the dedicated thread) to go to market? How should your marketing look like?
I will fully embrace my role of a client and ask hard questions other prospects might also ask before, during or after sales and implementation 
And offer honest feedback where it can help, of course. I’ll schedule a call with Matthias, but it might be interesting for whoever will do the “business development” on this to listen in.